requiring treatment with dexamethasone – The ACED trial: ID1098932 Ref: Adjuvant chemotherapy with gemcitabine and cisplatin Priority Driven compared to observation Collaborative Cancer University of after curative intent resection The University of Cancer $497,544 29/02/2016 36 2006 Australia Sydney of cholangiocarcinoma and Sydney Research muscle invasive gallbladder Scheme carcinoma (ACTICCA-1 Trial): ID1100306 Ref: CA-G1516/25 Long-term follow-up of the Priority Driven Laparoscopic Approach to Collaborative Cancer University of Carcinoma of the Cancer $380,674 07/03/2016 24 St Lucia 4072 Australia Queensland Endometrium (LACE) Trial – Research survival outcomes: ID1098905 Scheme Ref: CA-G1516/28 Priority Driven CaPP3: a randomized double Collaborative Cancer blind dose inferiority trial of Cancer Melbourne Health $290,340.50 11/03/2016 36 Parkville 3056 Australia aspirin in Lynch Syndrome: Research ID1103035 Ref: CA-G1516/29 Scheme Priority Driven A novel approach to Collaborative Cancer Garvan Institute of overcome Cancer $415,770 11/03/2016 36 Darlinghurst 2010 Australia Medical Research in breast cancer: Research ID1107170 Ref: CA-G1516/30 Scheme Translating Evidence into Priority Driven Practice: Optimising and Collaborative Facilitating Prevention and Cancer University of Cancer Screening in Women with a $258,345 15/03/2016 36 Parkville 3010 Australia Melbourne Research Strong Family History of Breast Scheme Cancer: ID1100868 Ref: Peter MacCallum Supporting Improving information Cancer Institute Cancer People with provision and support for T/A Peter $132,000 30/03/2016 25 Melbourne 3000 Australia Cancer Grant underserved cancer survivors. MacCallum initiative Ref: CA-G1516/36 Cancer Centre
requiring treatment with dexamethasone – The ACED trial: ID1098932 Ref: Cancer Australia Priority Driven Collaborative Cancer Research Scheme University of Sydney Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 Trial): ID1100306 Ref: CA-G1516/25 $497,544 29/02/2016 36 The University of Sydney 2006 Cancer Australia Priority Driven Collaborative Cancer Research Scheme University of Queensland Long-term follow-up of the Laparoscopic Approach to Carcinoma of the Endometrium (LACE) Trial – survival outcomes: ID1098905 Ref: CA-G1516/28 $380,674 07/03/2016 24 St Lucia 4072 Cancer Australia Priority Driven Collaborative Cancer Research Scheme Melbourne Health CaPP3: a randomized double blind dose inferiority trial of aspirin in Lynch Syndrome: ID1103035 Ref: CA-G1516/29 $290,340.50 11/03/2016 36 Parkville 3056 Cancer Australia Priority Driven Collaborative Cancer Research Scheme Garvan Institute of Medical Research A novel approach to overcome in breast cancer: ID1107170 Ref: CA-G1516/30 $415,770 11/03/2016 36 Darlinghurst 2010 Cancer Australia Priority Driven Collaborative Cancer Research Scheme University of Melbourne Translating Evidence into Practice: Optimising and Facilitating Prevention and Screening in Women with a Strong Family History of Breast Cancer: ID1100868 Ref: $258,345 15/03/2016 36 Parkville 3010 Cancer Australia Supporting People with Cancer Grant initiative Peter MacCallum Cancer Institute T/A Peter MacCallum Cancer Centre Improving information provision and support for underserved cancer survivors. Ref: CA-G1516/36 $132,000 30/03/2016 25 Melbourne 3000
grants_reporting_20170703_3.docx